Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
Joanne R Chalmers(University of Nottingham), Natasha K Rogers(University of Nottingham), Michaela Nygårdas, L Howie, Emi Ono(The University of Osaka), Yoko Kataoka(Shiga University of Medical Science), Henrique Akira Ishii(Universidade de São Paulo), Valéria Aoki(Universidade de São Paulo), Hywel C Williams(University of Nottingham), Kim S Thomas(University of Nottingham), Yukihiro Ohya(Nagoya City University), Marius Ardeleanu(Regeneron (United States)), Eli Synnøve Gjerde, Amy M. DeLozier(Eli Lilly (United States)), Carsten Flohr(King's College London), Lisa Butler(Queen's University), Laura Howells(University of Nottingham), S. Barbarot(Hotel Dieu Hospital), Fabio P. Nunes(Eli Lilly (United States)), Wim Kouwenhoven, Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), Maarten Boers(Amsterdam University Medical Centers), C.A.C. Prinsen(Amsterdam Neuroscience), Laurent Eckert(Sanofi (France)), Eckard Rehbinder(Oslo University Hospital), Yael A. Leshem(Tel Aviv University), Uffe Nygaard(Aarhus University Hospital), Stéphanie Mérhand(National Eczema Association), Carol Hawkes(GlaxoSmithKline (United Kingdom)), B K Bang(Leo Pharma (Denmark)), Lawrence F. Eichenfield(University of California San Diego), Phyllis I. Spuls, Christian Apfelbacher(Heidelberg University), Katrina Abuabara(University of Electronic Science and Technology of China), Masaki Futamura, Karlijn F. van Halewijn(Erasmus MC), Teresa Løvold Berents(Oslo University Hospital), Hiroyuki Murota(Nagasaki University), Paola Mina‐Osorio(Regeneron (United States)), T. Chubachi(Research Triangle Park Foundation), E. Simpson(Oregon Health & Science University), Tim Burton, John Armstrong(Galderma (France)), A. Gadkari(Regeneron (United States)), Rosemary Humphreys(National Eczema Society), Ichiro Katayama(The University of Osaka), T. Nakahara(Kyushu University), Sinéad Langan(London School of Hygiene & Tropical Medicine), J.F. Stalder(Centre Hospitalier Universitaire de Nantes), Amanda Cresswell-Melville
Cited by 160
Related Papers
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
|PLoS Medicine|2015|5.2k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k